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Abstract 
Background: This prospective randomized controlled clinical study aimed to investigate the effect of 
magnesium sulfate (MgSO4) on pain management post orthognathic surgery. 
Methods: In this study, 52 patients undergoing orthognatic surgery were randomly allocated to receive MgSO4 
or saline intravenously. The intervention group (n = 26) received intravenous MgSO4 (30 mg/kg bolus for 
15 minutes immediately before anesthesia induction followed by 10 mg/kg/h dissolved in saline via pump 
infusion) and the second group (n = 26) received the placebo in the same bolus volume as a normal saline in a 
15 minute intravenous infusion which was continued until the end of the operation. A visual analog scale 
(VAS) was used to determine the intensity of pain. Invasive arterial blood pressure and valid and invalid 
analgesic demand were also recorded. Side effects were recorded, as well. 
Results: This study was conducted on 52 patients, 26 per group. The results showed no statistically significant 
differences between the two groups with respect to demographics. During the post-operative period, the 
patients in the control group showed larger analgesic requirement 7 (26.9%) compared to those in the 
magnesium group 4 (15.4%) and the difference was not statistically significant (P = 0.308). The post-operative 
VAS scores evaluated serially from the recovery room also showed a significant difference between the 
intervention 3 (11.5%) and the control group 14 (53.8%) after the surgery (P = 0.001). However, no significant 
difference was found between the two groups regarding VAS scores in the surgical ward [7 (26.9%) vs. 8 
(30.8%) P = 0.760].
Conclusions: Intra-operative administration of intravenous MgSO4 reduced opioid consumption for pain after 
bimaxillary orthognathic operations. 
© 2016 Tehran University of Medical Sciences. All rights reserved. 
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Introduction
A pain resulting from surgery is deleterious and can 
lead to post-operative complications if inadequately 
relieved (1). Magnesium sulfate (MgSO4) has been 
used as an intravenous adjuvant to analgesics in the 
perioperative period (2). MgSO4 acts as a physiologic 
calcium-channel blocker (3-5). Magnesium, which is a 
natural calcium antagonist, is an antagonist of the N-
methyl-D-aspartate (NMDA) receptor that is a crucial 
element for enzymes function, neurotransmission, and 
cell signaling (6,7). NMDA receptor antagonists can 
prevent central sensitization because of peripheral 
nociceptive stimulation and abolish this 
hypersensitivity when it is established (7,8). Therefore, 
substances with calcium-channel blocker effect and 
NMDA antagonism can play a role in the prevention of 
pain, sensitization processes, and hyperalgesia in the 
early post-operative period (9,10). Magnesium is the 
fourth most common mineral salt in human body and 
contributes to muscle contraction, conduction of 
neuronal and pain impulses, and vascular tone 
regulation (4,5). Some studies have clearly shown that 
MgSO4 reduces post-operative morphine requirement 
after remifentanil-based anesthesia (11). Similarly, it 
can reduce intra-operative and post-operative analgesic 
requirement in patients undergoing major lumbar 
orthopedic surgery (12). Opioid-induced hyperalgesia 
is defined as a state of nociceptive sensitization, which 
is characterized by a paradoxical response, whereby a 
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patient receiving opioids for pain treatment might have 
an increased sensitivity to painful stimuli. However, 
concerns have been raised after reports indicated higher 
pain scores and exaggerated post-operative opioid 
consumption, suggesting the development of acute 
opioid tolerance and opioid-induced hyperalgesia in 
patients receiving a perioperative remifentanil infusion. 
Clinicians need to be cautious for the possibility of the 
development of opioid-induced hyperalgesia and 
opioid tolerance, which may impair treatment of pain 
or even aggravate preexisting pain (13).
Based on these studies, this randomized double-
blind clinical trial aims to evaluate the analgesic effect 
of intra-operative MgSO4 infusion administered 
intravenously on post-operative analgesic requirement, 
pain management, and side effects after orthognathic 
surgery. The investigators hypothesized that MgSO4
could decrease morphine consumption and provide 
better pain relief after orthognathic surgery. 
Materials and Methods 
At first, the researchers gained the approval of the local 
Research Ethics Committee of Shiraz University of 
Medical Sciences and obtained written informed 
consents from the participants. Then, 52 patients with 
physical Status I according to the American Society of 
Anesthesiologists (ASA) undergoing bimaxillary 
orthognatic surgery were enrolled into this double-
blinded, prospective, randomized trial 
[IRCT201307101674N7 (www.irct.ir)]. All the 
operations were performed by the same surgical team. 
The patients with hepatic, renal, or cardiovascular 
dysfunction, chronic obstructive pulmonary disease, 
asthma, heart block, myocardial damage, morbid 
obesity (body mass index  35), neuromuscular 
disease, history of neuropathy, history of using opioid 
or analgesics 3 days before the study, and history of 
using calcium channel blockers and those who were 
not willing to take part in the study were excluded. The 
study participants were required to fast for 6 hours 
before the surgery, and no premedication was given. 
The anesthetic method for surgery was similar for all 
the patients. Morphine 0.1 mg/kg was administered 
intravenously at induction of anesthesia which was 
achieved using 2-2.5 mg/kg propofol, 2-3 μ/kg 
fentanyl, and 0.5 mg/kg atracurum. Anesthesia was 
maintained using 6-12 mg/kg/h propofol and 
remifentanil by infusion. The patients were 
mechanically ventilated to keep EtCO2 between 35 and 
40 mm Hg and normothermia was maintained in the 
operation theater. The patients were selected through 
convenience sampling and were randomly divided into 
two groups via computer-generated table of random 
numbers. The randomization was performed by the 
random number generator and using permutation 
method. The sampling was also based on simple 
purposive method so if the selected person was not 
placed in the sample group, the another person was 
selected. The medications were prepared and randomly 
coded by nurses who were totally unaware of the 
nature of the study. The anesthesiologist and surgeon 
were also unaware of the content of injections. The 
patients in the intervention group received an 
intravenous MgSO4 30 mg/kg body weight bolus for 
15 minutes followed by 10 mg/kg/h dissolved in saline 
via pump infusion. The control group, on the other 
hand, received the placebo in same bolus volume as 
normal saline in a 15-minutes intravenous infusion 
continued until the end of the operation. Intra-operative 
monitoring included invasive-arterial blood pressure, 
electrocardiograph, and peripheral oxygen saturation. 
A visual analog scale (VAS) was used to assess the 
intensity of pain (0 = no pain and 10 = worst pain 
imaginable) and the effectiveness of the administered 
analgesics. At the end of the surgical procedure, all the 
infusions were stopped, and the residual neuromuscular 
block was reversed using neostigmine (0.05 mg/kg) 
and atropine (0.02 mg/kg). All the patients were 
monitored in the post-anesthesia recovery room for the 
first 6 hours. Post-operative monitoring included heart 
rate, non-invasive blood pressure, and pulse oximetry. 
During these 6 hours, the patients were kept in the 
recovery room and rescue analgesia was provided at 
VAS  3 in the form of intravenous morphine 
0.1 mg/kg. In the surgical ward, administration of 
analgesics was recorded for 12 hours. Then, the 
patients’ post-operative complications were recorded in 
a questionnaire. The incidence rates of bleeding, 
shivering, blood pressure changes, agitation and post-
operative nausea and vomiting were also recorded after 
the surgery. 
The data have been reported as mean ± standard 
deviations. Continuous variables, such as demographic 
data (age, height, and weight) and duration of 
surgeries, were analyzed using independent sample t-
test. Besides, the effectiveness of blood-pressure 
lowering drugs was assessed by repeated measures 
ANOVA. In addition, chi-square and Fisher’s exact 
tests were used to analyze VAS pain scores and 
morphine consumption. All the analyses were 
performed using the SPSS for Windows (version 10; 
SPSS Inc., Chicago, USA), and P < 0.050 was 
considered as statistically significant.  
Results 
This study was conducted on 52 patients, 26 per group. 
The study results showed no statistically significant 
difference between the two groups regarding age, sex, 
weight, and height (P > 0.050). The surgery lasted for 
were 261.9 ± 56.0 and 234.0 ± 38.9 minutes in the 
MgSO4 and control groups, respectively, the difference 
was statistically significant (P = 0.044) (Table 1). 
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Table 1. The demographic characteristics of the study patients 
Characteristics Control (n = 26) Mg (n = 26) P value 
Age (years) 23.4 ± 5.3 22.3 ± 5.2 0.447
Sex (F/M) 11/15 9/17 0.569 
Weight (kg) 61.4 ± 11.0 60.4 ± 9.1 0.742 
Height (cm) 169.3 ± 9.2 167.0 ± 7.8 0.538 
Duration of operation (min) 261.9 ± 56.0 234.0 ± 38.9 0.044
During the post-operative period, the patients in the 
control group showed larger analgesic requirement  
(7, 26.9%) compared to those in the magnesium group 
(4, 15.4%) and the difference was not statistically 
significant (P = 0.308). However, a significant 
difference was observed between the intervention and 
the control group regarding post-operative VAS scores 
evaluated serially from the recovery room (3, 11.5% 
vs. 14, 53.8%; P = 0.001). On the other hand, no 
significant difference was found between the two 
groups regarding VAS scores in the surgical ward  
(7, 26.9% vs. 8, 30.8%; P = 0.760). 
In the MgSO4 and control group, systolic and 
diastolic blood pressure decreased during operation 
significantly compared to the baseline. Besides, blood 
pressure increased after the operation. Furthermore, the 
mean of systolic blood pressure was lower in the 
magnesium group compared to the control group. 
However, the trend of changes in systolic and  
diastolic blood pressure was not statistically  
significant in MgSO4 and control groups  
(Figures 1 and 2).  
The results showed no significant difference between 
the two groups regarding the incidence of bleeding, 
shivering, blood pressure changes, agitation, nausea, and 
vomiting were 11.5%, 30.8%, 3.8%, 7.6%, and 3.8% in 
MgSO4 group and 7.6%, 23.1%, 0.0%, 11.5%, and 3.8% 
in control group, respectively. 
Figure 1. Trend of systolic blood pressure between two groups 
Figure 2. Trend of diastolic blood pressure between two groups
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Nonetheless, no incidence of bradycardia, hypoxia 
or hypoventilation was recorded during the post-
operative periods. 
Discussion 
This study assessed the possible effects of infusion of 
MgSO4 started before induction of anesthesia and 
continued throughout the procedure on reducing the 
analgesic requirement and post-operative pain in the 
patients undergoing bimaxillary orthognatic surgery. In 
this study, 30 mg/kg MgSO4 was administered as a 
bolus followed by 10 mg/kg/h infusion intra-
operatively. No complications resulting from 
magnesium administration were evident at the used 
doses. Magnesium, which acts as the NMDA receptor 
antagonist, may play a role in prevention and treatment 
of perioperative pain. Some studies have indicated that 
MgSO4 led to a reduction in analgesic consumption 
during the intra-operative (14,15) and post-operative 
periods (12,16,17). However, Ko et al. (18) reported 
that intravenous MgSO4 had no analgesic efficacy and 
caused no reduction in post-operative analgesic 
requirement. In our study, on the other hand, 
administration of intra-operative MgSO4 resulted in 
superior pain relief. Similar results were also obtained 
by Levaux et al. (12). Mentes and colleagues (16) also 
revealed the efficacy of MgSO4 in reducing post-
operative pain following major lumbar orthopedic 
surgery and laproscopic cholecystectomy. In addition, 
using MgSO4 was associated with significantly less 
analgesic requirement in the patients undergoing lower 
limb operations (17) and abdominal hysterectomy (18) 
in the post-operative period (19,20). 
The effect of magnesium on perioperative analgesic 
requirement was first evaluated by Koinig and 
colleagues (21) in patients with identical levels of 
surgical stimulation. Their results demonstrated that 
magnesium could be an adjuvant to per-operative 
analgesic management by lowering the fentanyl 
requirement. Tramer et al. (22) were the first to show 
that magnesium administration significantly reduced 
analgesic requirement. They found that the patients 
who had received magnesium required significantly 
less morphine compared to those in the control group 
during the post-operative period and this was most 
pronounced during the first 6 hours. Moreover, Kaur 
and Baghla (1) showed that administration of 30 mg/kg 
MgSO4 bolus before induction followed by 10 mg/kg/h 
by infusion intra-operatively significantly reduced 
post-operative pain in the patients undergoing upper 
limb orthopedic surgery without any significant 
increase in the adverse effects. Furthermore, some 
researchers (11) believed that MgSO4 in a 30 mg/kg 
bolus with 500 mg/h intra-operative continuous 
infusion significantly decreased post-operative 
morphine usage as well as early post-operative VAS 
scores. In contrast, Ko et al. (18) suggested that 
perioperative infusion of MgSO4 neither increased the 
amount of MgSO4 in the cerebrospinal fluid nor did it 
decrease the post-operative pain. However, we think 
that intra-operative MgSO4 administration has a 
coanalgesic effect at least in patients receiving 
remifentanil during the intra-operative period and can 
reduce the analgesic requirement in patients 
undergoing bimaxillary orthognatic surgery.  
Ko et al. (18) used magnesium during abdominal 
hysterectomy. After induction of anesthesia, they used 
a 50 mg/kg bolus dose followed by intravenous 
infusion of 15 mg/kg/h for 6 hours. Cerebrospinal fluid 
magnesium concentration was measured at the end of 
the surgery, indicating an inverse relationship between 
cumulative post-operative analgesic consumption and 
cerebrospinal fluid magnesium concentration. It was 
also realized that magnesium had no effects on post-
operative pain. Our data with pre- and intra-operative 
administration of MgSO4 at 30 mg/kg bolus and 
maintenance of 10 mg/kg/h demonstrated a significant 
reduction in the post-operative analgesic consumption 
without any notable side effects. Ozcan et al. (23) also 
concluded that MgSO4 (30 mg/kg bolus and10 mg/kg/h 
infusion for 48 hours) was associated with a decrease 
in intravenous morphine requirement during the first  
48 hours after thoracotomies. In this study, morphine 
consumption was lower in the magnesium group after  
6 and 12 hours. In a meta-analysis in 2013, the effect of 
perioperative administration of MgSO4 on post-
operative pain was evaluated in 25 trials comparing 
magnesium with placebo were identified. Independent 
of the mode of administration (bolus or continuous 
infusion), perioperative magnesium reduced 
cumulative intravenous morphine consumption by 
24.4% at 24 hours postoperatively (24). In our study, 
similar to the previous reports, intravenous MgSO4
infusion reduced post-operative pain and analgesic 
consumption in the patients undergoing bimaxillary 
orthognatic surgery without any notable complications. 
Furthermore, no hemodynamic alterations, such as 
hypotension or bradycardia, occurred in this study. 
Therefore, the MgSO4 bolus and maintenance doses 
used in our study appear to be safe in the post-
operative period. 
This study had some limitations. For example, 
MgSO4 potentiates the effect of neuromuscular 
blocking agents (25,26). However, we could not 
monitor neuromuscular block. Yet, atracurium 
prolonged the duration of neuromuscular blockade 
although it could not be measured in our study. One 
other limitation of this study was that we did not 
measure serum magnesium concentration because of 
lack of the required facilities at our institute. 
Conclusion 
In summary, intravenous MgSO4 following general 
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anesthesia reduced post-operative pain and 
consumption of opioids after bimaxillary orthognathic 
procedures. Thus, administration of 30 mg/kg MgSO4
before induction as bolus followed by 10 mg/kg/h by 
intra-operative infusion significantly reduced post-
operative pain in the patients undergoing bimaxillary 
orthognathic surgery without any significant increase 
in the adverse effects.
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